191 – 200 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Medial Temporal Lobe Atrophy Increases the Specificity of Cerebrospinal Fluid Biomarkers in Alzheimer Disease with Minor Cerebrovascular Changes.
(
- Contribution to journal › Article
-
Mark
Long-term rivastigmine treatment in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
EVOLUTION OF A beta 42 AND A beta 40 LEVELS AND A beta 42/A beta 40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
(
- Contribution to journal › Article
-
Mark
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Total Tau Is Associated with Shorter Survival in Dementia with Lewy Bodies.
(
- Contribution to journal › Article
-
Mark
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity.
(
- Contribution to journal › Article
-
Mark
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests.
(
- Contribution to journal › Article